These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5115827)

  • 1. Medroxyprogesterone acetate (Provera) in the treatment of metastatic renal cancer.
    Bloom HJ
    Br J Cancer; 1971 Jun; 25(2):250-65. PubMed ID: 5115827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal treatment of metastases of renal carcinoma.
    van der Werf-Messing B; van Gilse HA
    Br J Cancer; 1971 Sep; 25(3):423-7. PubMed ID: 5144516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal therapy in advanced renal cell carcinoma.
    Wagle DG; Murphy GP
    Cancer; 1971 Aug; 28(2):318-21. PubMed ID: 5566354
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of the female metastatic hypernephroma.
    Tucker WG
    Mich Med; 1973 Aug; 72(24):525-8. PubMed ID: 4726736
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
    Klaassen DJ; Rapp EF; Hirte WE
    Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of progestogen in the treatment of metastatic carcinoma of the kidney and uterine body.
    Paine CH; Wright FW; Ellis F
    Br J Cancer; 1970 Jun; 24(2):277-82. PubMed ID: 5451569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of metastasizing hypernephroid (renal cell) carcinoma with medroxyprogesterone acetate (Clinovir) (author's transl].
    von Lieven H; Hahn D
    MMW Munch Med Wochenschr; 1977 Aug; 119(34):1089-92. PubMed ID: 408657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant medroxyprogesterone acetate to radical nephrectomy in renal cancer: 5-year results of a prospective randomized study.
    Pizzocaro G; Piva L; Di Fronzo G; Giongo A; Cozzoli A; Dormia E; Minervini S; Zanollo A; Fontanella U; Longo G
    J Urol; 1987 Dec; 138(6):1379-81. PubMed ID: 2824861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [the oral use of a progestational hormone (Provera 100) as an adjuvant in therapy of adenocarcinoma of the kidney. Preliminary report].
    Liberti M; Di Silverio F; Concolino G; Tenaglia R; Marocchi A
    Minerva Urol; 1980; 32(3):175-8. PubMed ID: 7432332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medroxyprogesterone in metastatic renal cell carcinoma.
    Rao MK; Soloway MS
    South Med J; 1980 Feb; 73(2):247-8. PubMed ID: 7355330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study.
    Gottesman JE; Crawford ED; Grossman HB; Scardino P; McCracken JD
    Urology; 1985 Mar; 25(3):248-50. PubMed ID: 3156442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormones in the treatment of metastatic renal cancer.
    Morales A; Kiruluta G; Lott S
    J Urol; 1975 Nov; 114(5):692-3. PubMed ID: 1185861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences with Depo-Provera (medroxyprogesterone) in the treatment of kidney tumors].
    Balogh F; Romics I
    Z Urol Nephrol; 1987 Aug; 80(8):449-53. PubMed ID: 2961162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
    Kjaer M; Frederiksen PL
    Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
    Katakkar SB; Franks CR
    Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal therapy in metastatic hypernephroma.
    Peterson LJ; Grimes JH; Dees JE; Anderson EE
    Urology; 1974 Dec; 4(6):669-73. PubMed ID: 4454105
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormone treatment of advanced renal cell carcinoma.
    Raghavaiah NV
    Urology; 1982 Feb; 19(2):123-6. PubMed ID: 7058601
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible role of hormones in treatment of metastatic testicular teratomas: tumour regression with medroxyprogesterone acetate.
    Bloom HJ; Hendry WF
    Br Med J; 1973 Sep; 3(5880):563-7. PubMed ID: 4726928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer of the urogenital tract: kidney. The basis for hormonal therapy.
    Bloom HJ
    JAMA; 1968 May; 204(7):605-6. PubMed ID: 5694486
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormonal therapy for metastatic renal cell carcinoma combined androgen and provera followed by high dose tamoxifen.
    Papac RJ; Keohane MF
    Eur J Cancer; 1993; 29A(7):997-9. PubMed ID: 8499154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.